• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Encompass Health Corporation filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

    5/2/25 2:33:00 PM ET
    $EHC
    Hospital/Nursing Management
    Health Care
    Get the next $EHC alert in real time by email
    ehc-20250501
    false000078516100007851612025-05-012025-05-01


    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    WASHINGTON, D.C. 20549
    FORM 8-K
    CURRENT REPORT
    Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934
    Date of Report (date of earliest event reported): May 1, 2025
    Encompass Health Corporation
    (Exact name of Registrant as specified in its Charter)
    Delaware
    (State or Other Jurisdiction of Incorporation)
    001-1031563-0860407
    (Commission File Number)(IRS Employer Identification No.)
    9001 Liberty Parkway, Birmingham, Alabama 35242
    (Address of Principal Executive Offices, Including Zip Code)
    (205) 967-7116
    (Registrant’s Telephone Number, Including Area Code)
    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
    ☐
    Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    ☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    ☐
    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    ☐
    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.     Emerging growth company   ☐
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
    Securities registered pursuant to Section 12(b) of the Act:
    Title of each classTrading Symbol(s)Name of each exchange on which registered
    Common Stock, par value $0.01 per shareEHCNew York Stock Exchange



    Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

    Compensatory Arrangements of Certain Officers.

    On May 1, 2025, the stockholders of Encompass Health Corporation (the “Company”) approved the 2025 Omnibus Performance Incentive Plan, attached to this report as Exhibit 10.1 and incorporated herein by reference, at the Company’s 2025 annual meeting of stockholders (the “Annual Meeting”).


    Item 5.07. Submission of Matters to a Vote of Security Holders.
    During the Annual Meeting on May 1, 2025, the stockholders of the Company voted on the following:
    1.election of the 10 persons nominated by the Company’s board of directors (the “Board”);
    2.ratification of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm;
    3.approval of the compensation of the Company’s named executive officers, as disclosed in the proxy statement filed on April 1, 2025 pursuant to the compensation disclosure rules of the Securities and Exchange Commission; and
    4.approval of the the Company’s 2025 Omnibus Performance Incentive Plan.
    As of the record date for the Annual Meeting, there were 100,967,059 shares of the Company’s common stock issued and outstanding. Each share of common stock was entitled to one vote on each matter properly brought before the Annual Meeting. The common stock voted together as a class. Votes representing 93.9% of the combined voting power of the common stock were represented by proxy at the Annual Meeting.
    The final voting results for the Annual Meeting were as follows:
    •Proposal 1, election of directors, each of the nominees was elected:
    Name of NomineeVotes For
    Votes
    Against
    Votes
    Abstained
    Greg D. Carmichael87,805,7602,107,01643,957
    Edward M. Christie III89,835,79378,87442,066
    Joan E. Herman88,463,8221,451,61041,301
    Leslye G. Katz88,349,6251,565,57741,531
    Patricia A. Maryland88,728,8171,186,05841,858
    Kevin J. O’Connor89,167,078741,07248,583
    Christopher R. Reidy88,773,7941,134,26948,670
    Nancy M. Schlichting89,294,817620,63241,284
    Mark J. Tarr89,683,285225,32748,121
    Terrance Williams89,806,099101,90148,733

    •Proposal 2, ratification of the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm, passed:
    Votes ForVotes AgainstVotes Abstained
    91,374,7553,403,77155,131
    •Proposal 3, approval of the compensation of the Company’s named executive officers, passed:
    Votes ForVotes AgainstVotes Abstained
    87,426,4502,187,504342,779




    •Proposal 4, approval of the the Company’s 2025 Omnibus Performance Incentive Plan, passed:
    Votes ForVotes AgainstVotes Abstained
    85,524,7384,376,18655,809
    Proposals 1, 3 and 4 each received 4,876,924 broker non-votes. There were no broker non-votes on Proposal 2.

    ITEM 9.01. Financial Statements and Exhibits.
    (d)    Exhibits.
    Exhibit NumberDescription
    10.1
    Encompass Health Corporation 2025 Omnibus Performance Incentive Plan.
    104Cover Page Interactive Data File - the cover page iXBRL tags are embedded within the Inline XBRL document




    Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.


    ENCOMPASS HEALTH CORPORATION
    By:
    /S/   Patrick Darby
    Name:Patrick Darby
    Title:Executive Vice President, General Counsel and Secretary

    Dated: May 2, 2025


    Get the next $EHC alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $EHC

    DatePrice TargetRatingAnalyst
    10/11/2024$115.00Overweight
    KeyBanc Capital Markets
    7/10/2024$100.00Outperform
    Leerink Partners
    3/6/2024$95.00Overweight
    Barclays
    3/14/2023$57.00Equal Weight
    Barclays
    2/7/2022$90.00 → $80.00Strong Buy
    Raymond James
    11/3/2021$94.00 → $80.00Buy
    Mizuho
    11/2/2021$107.00 → $90.00Strong Buy
    Raymond James
    10/13/2021$100.00 → $88.00Buy
    Truist Securities
    More analyst ratings

    $EHC
    SEC Filings

    See more
    • Encompass Health Corporation filed SEC Form 8-K: Regulation FD Disclosure

      8-K - Encompass Health Corp (0000785161) (Filer)

      6/3/25 4:21:59 PM ET
      $EHC
      Hospital/Nursing Management
      Health Care
    • Encompass Health Corporation filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

      8-K - Encompass Health Corp (0000785161) (Filer)

      5/2/25 2:33:00 PM ET
      $EHC
      Hospital/Nursing Management
      Health Care
    • SEC Form 10-Q filed by Encompass Health Corporation

      10-Q - Encompass Health Corp (0000785161) (Filer)

      5/1/25 3:25:31 PM ET
      $EHC
      Hospital/Nursing Management
      Health Care

    $EHC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Carmichael Greg D bought $167,460 worth of Encompass Health Common Stock (2,000 units at $83.73), increasing direct ownership by 13% to 17,050 units (SEC Form 4)

      4 - Encompass Health Corp (0000785161) (Issuer)

      5/7/24 11:44:12 AM ET
      $EHC
      Hospital/Nursing Management
      Health Care

    $EHC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • President & CEO Tarr Mark J exercised 118,384 units of Encompass Health Common Stock at a strike of $40.10 and sold $14,387,152 worth of Encompass Health Common Stock (118,384 units at $121.53) (SEC Form 4)

      4 - Encompass Health Corp (0000785161) (Issuer)

      5/20/25 5:08:49 PM ET
      $EHC
      Hospital/Nursing Management
      Health Care
    • Sr. Vice Pres. and Treasurer Fay Edmund gifted 3,667 units of Encompass Health Common Stock, decreasing direct ownership by 4% to 96,489 units (SEC Form 4)

      4 - Encompass Health Corp (0000785161) (Issuer)

      5/15/25 2:10:54 PM ET
      $EHC
      Hospital/Nursing Management
      Health Care
    • Chief Medical Officer Charbonneau Elissa Joy sold $498,974 worth of Encompass Health Common Stock (4,279 units at $116.61), decreasing direct ownership by 26% to 11,958 units (SEC Form 4)

      4 - Encompass Health Corp (0000785161) (Issuer)

      5/7/25 1:07:09 PM ET
      $EHC
      Hospital/Nursing Management
      Health Care